1. ACTR-12. PHASE 2 STUDY OF DIANHYDROGALACTITOL (VAL-083) IN PATIENTS WITH MGMT-UNMETHYLATED, BEVACIZUMAB-NAÏVE GLIOBLASTOMA IN THE RECURRENT AND ADJUVANT SETTING. (11th November 2019) Authors: O'Brien, Barbara; Penas-Prado, Marta; Kamiya, Carolos; Pei Weathers, Shiao-; Yung, Alfred; Loghin, Monica; Harrison, Rebecca; Bacha, Jeffrey; Brown, Dennis; Johnson, Gregory; Langlands, John; Schwartz, Richard; Kanekal, Sarath; Lopez, Lorena; deGroot, John Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗